UnknownNot applicableNCT05372926

Physiological Effects of HFNC During Exercise in Patients With Fibrosing Interstitial Lung Diseases

Studying Interstitial lung disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
ADIR Association
Principal Investigator
Elise ARTAUD-MACARI, MD
ADIR Association
Intervention
high flow nasal canulae(device)
Enrollment
16 target
Eligibility
18 years · All sexes
Timeline
2022 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05372926 on ClinicalTrials.gov

Other trials for Interstitial lung disease

Additional recruiting or active studies for the same condition.

See all trials for Interstitial lung disease →

← Back to all trials